Buchbinder Aby (CIK 0001526633)

Latest company ownership

Role: VP, Clinical Development
Shares held
79,246
Last filed at
Jan 25, 2013
Confidence Score
50.0
2025Q4
Confidence Score History
2011Q3 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Nov 8, 2011 Nov 10, 2011 ENZON PHARMACEUTICALS, INC. VP, Clinical Development Sell 26.3 -2,700 -4.76% $19.1K
Sep 15, 2011 Sep 19, 2011 ENZON PHARMACEUTICALS, INC. VP, Clinical Development Sell 26.3 -2,952 -4.95% $24.6K